Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis

Approximately 70% of the patients with systemic lupus erythematosus will have clinical evidence of kidney damage during their evolution. Patients with impaired renal function at onset and those with recurrent flares have a poor prognosis. Understanding the mechanism of action of immunosuppressants i...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamilla-Sanchez, Mario E, Alcala-Salgado, Miguel A, Alonso-Bello, Cesar D, Fonseca-Gonzalez, Gandhy T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675090/
https://www.ncbi.nlm.nih.gov/pubmed/34924767
http://dx.doi.org/10.2147/IJNRD.S335371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675090/
https://www.ncbi.nlm.nih.gov/pubmed/34924767
http://dx.doi.org/10.2147/IJNRD.S335371

Ejemplares similares